Analysts Set Aspen Aerogels, Inc. (NYSE:ASPN) Target Price at $19.50

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) has received an average rating of “Moderate Buy” from the eleven brokerages that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $19.50.

Several brokerages recently commented on ASPN. Barclays cut Aspen Aerogels from an “equal weight” rating to an “underweight” rating and boosted their target price for the stock from $7.00 to $16.00 in a report on Monday, August 11th. Canaccord Genuity Group dropped their target price on Aspen Aerogels from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Friday, August 8th. Finally, Weiss Ratings reissued a “sell (d)” rating on shares of Aspen Aerogels in a report on Saturday, September 27th.

View Our Latest Research Report on Aspen Aerogels

Aspen Aerogels Trading Up 7.6%

Aspen Aerogels stock opened at $7.76 on Friday. The firm’s 50-day moving average is $7.10 and its 200-day moving average is $6.44. The company has a debt-to-equity ratio of 0.34, a quick ratio of 3.31 and a current ratio of 3.98. Aspen Aerogels has a 1 year low of $4.16 and a 1 year high of $26.90. The company has a market cap of $638.70 million, a P/E ratio of -2.04 and a beta of 2.80.

Aspen Aerogels (NYSE:ASPNGet Free Report) last posted its earnings results on Thursday, August 7th. The construction company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.08. The firm had revenue of $78.02 million during the quarter, compared to analysts’ expectations of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. Aspen Aerogels’s quarterly revenue was down 33.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.21 EPS. Aspen Aerogels has set its FY 2025 guidance at -3.860–3.730 EPS. On average, equities analysts expect that Aspen Aerogels will post 0.17 earnings per share for the current year.

Insider Buying and Selling

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the business’s stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total transaction of $32,237.10. Following the sale, the chief accounting officer owned 19,879 shares of the company’s stock, valued at $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 4.30% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ASPN. Gagnon Securities LLC bought a new position in shares of Aspen Aerogels in the second quarter valued at $11,243,000. Federated Hermes Inc. bought a new position in shares of Aspen Aerogels in the second quarter valued at $10,459,000. AWM Investment Company Inc. increased its holdings in shares of Aspen Aerogels by 102.6% in the first quarter. AWM Investment Company Inc. now owns 2,449,221 shares of the construction company’s stock valued at $15,651,000 after buying an additional 1,240,535 shares in the last quarter. Invesco Ltd. increased its holdings in shares of Aspen Aerogels by 1,045.5% in the second quarter. Invesco Ltd. now owns 831,991 shares of the construction company’s stock valued at $4,925,000 after buying an additional 759,360 shares in the last quarter. Finally, MetLife Investment Management LLC increased its holdings in shares of Aspen Aerogels by 2,036.3% in the first quarter. MetLife Investment Management LLC now owns 764,423 shares of the construction company’s stock valued at $4,885,000 after buying an additional 728,641 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Featured Articles

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.